Clinical Trial Detail

NCT ID NCT01801358
Title A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Novartis|Novartis Pharmaceuticals
Indications

ocular melanoma

Therapies

Binimetinib

AEB071 + Binimetinib

Age Groups: adult

No variant requirements are available.